BOT 5.22% 35.3¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,685 Posts.
    lightbulb Created with Sketch. 108
    No probs.

    Hence my questioning earlier.. they appear in 20th now, but their original 7.1 mill holding is gone from the top 20 if I am correct..

    Yes they were lead manager of the last CR from memory.

    As per recent broker report from Argonaut:

    https://www.botanixpharma.com/wp-content/uploads/2018-11-21-Botanix-BOT-Argonaut-Company-Update.pdf

    "Important Disclosure Argonaut acted as Joint Lead Manager to the Placement that raised $15.0M in February 2018 and received fees commensurate with this service. Argonaut acted as Joint Lead Manager to the Placement that raised $8.0M in June 2018 and received fees commensurate with this service. Argonaut holds or controls 12.1M BOT Options exercisable at $0.03 on or before 30 June 2019."
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.3¢
Change
0.018(5.22%)
Mkt cap ! $707.4M
Open High Low Value Volume
33.5¢ 36.0¢ 33.3¢ $2.274M 6.550M

Buyers (Bids)

No. Vol. Price($)
13 88831 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 95849 13
View Market Depth
Last trade - 14.39pm 26/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.